XML 66 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Restatement of Financial Statements (Tables)
3 Months Ended
Mar. 31, 2019
Accounting Changes and Error Corrections [Abstract]  
Restatement of Financial Statements

The table below sets forth the impact of the restatement on the Consolidated Statement of Operations (unaudited).





 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

Three Months Ended March 31, 2019



 

As Previously Reported

 

Adjustment

 

As Restated

Operating Costs and Expense:

 

 

 

 

 

 

 

 

 

Amortization

 

$

200 

 

$

(124)

 

$

76 

Total operating costs and expense

 

 

50,641 

 

 

(124)

 

 

50,517 

Operating loss

 

 

(4,052)

 

 

124 

 

 

(3,928)

Other income, net

 

 

897 

 

 

(68)

 

 

829 

Loss Before Income Taxes

 

 

(3,155)

 

 

56 

 

 

(3,099)

Income tax benefit

 

 

(143)

 

 

(821)

 

 

(964)

Net Loss

 

 

(3,012)

 

 

877 

 

 

(2,135)



 

 

 

 

 

 

 

 

 

Per Share Basis

 

 

 

 

 

 

 

 

 

Net loss

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.14)

 

$

0.04 

 

$

(0.10)



 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



The table below sets forth the impact of the restatement on the Consolidated Statement of Comprehensive Income (Loss) (unaudited).





 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

Three Months Ended March 31, 2019



 

As Previously Reported

 

Adjustment

 

As Restated

Net Loss

 

$

(3,012)

 

$

877 

 

$

(2,135)

Total Comprehensive Loss

 

 

(2,949)

 

 

877 

 

 

(2,072)



The table below sets forth the impact of the restatement on the Consolidated Balance Sheet (unaudited).





 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

March 31, 2019



 

As Previously Reported

 

Adjustment

 

As Restated

Assets

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

$

3,074 

 

$

(2,846)

 

$

228 

Goodwill

 

 

13,973 

 

 

(13,973)

 

 

 —

Deferred income taxes, net

 

 

6,720 

 

 

(2,362)

 

 

4,358 

Total assets

 

 

155,432 

 

 

(19,181)

 

 

136,251 

Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

 

 

Other accrued expense

 

$

6,635 

 

$

(338)

 

$

6,297 

Total current liabilities

 

 

29,138 

 

 

(338)

 

 

28,800 

Other liabilities

 

 

4,696 

 

 

68 

 

 

4,764 

Total liabilities

 

 

89,855 

 

 

(270)

 

 

89,585 

Accumulated deficit

 

 

(378,526)

 

 

(18,911)

 

 

(397,437)

Total shareholders’ equity

 

 

65,577 

 

 

(18,911)

 

 

46,666 

Total liabilities and shareholders’ equity

 

 

155,432 

 

 

(19,181)

 

 

136,251 



The table below sets forth the impact of the restatement on the Consolidated Statement of Cash Flows (unaudited).





 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

Three Months Ended March 31, 2019



 

As Previously Reported

 

Adjustment

 

As Restated

Operating Activities

 

 

 

 

 

 

 

 

 

Net loss

 

$

(3,012)

 

$

877 

 

$

(2,135)

Adjustments to reconcile net loss to net cash provided by (used for) operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

$

2,586 

 

$

(124)

 

$

2,462 

Deferred income taxes

 

 

(303)

 

 

(483)

 

 

(786)

Changes in working capital and other operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Other accrued expenses

 

$

865 

 

$

(270)

 

$

595